B&A Genetics Competitors

About Genomic Health Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that help optimize cancer care by addressing the overtreatment of the disease, one of the greatest issues in healthcare today. With its Oncotype IQ® Genomic Intelligence Platform, the company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of clinical and genomic big data into actionable results for treatment planning throughout the cancer patient journey, from diagnosis to treatment selection and monitoring. The Oncotype IQ portfolio of genomic tests and services currently consists of the company's flagship line of Oncotype DX gene expression tests that have been used to guide treatment decisions for more than 750,000 cancer patients worldwide. Genomic Health is expanding its test portfolio to include additional liquid- and tissue-based tests, including the recently launched Oncotype SEQ® Liquid Select™ test. The company is based in Redwood City, California, with international headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth, Facebook, YouTube and LinkedIn. About Oncotype DX® The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. The company's flagship product, the Oncotype DX Breast Recurrence Score®, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer. Additionally, the Oncotype DX Breast DCIS Score™ predicts the likelihood of recurrence in a pre-invasive form of breast cancer called DCIS. In prostate cancer, the Oncotype DX Genomic Prostate Score™ predicts disease aggressiveness and further clarifies the current and future risk of the cancer prior to treatment intervention. With more than 750,000 patients tested in more than 90 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. To learn more about Oncotype DX tests, visit www.OncotypeIQ.com, www.MyBreastCancerTreatment.org or www.MyProstateCancerTreatment.org.

Precision Genetics provides full-scale lab and genetics testing solutions including COVID, and pharmacogenomics (PGx) for perioperative and mental health to improve overall patient outcomes. By combining evidence-based technology and population risk analysis into a comprehensive and actionable solution, we allow busy providers to immediately deliver individualized treatment and prevention plans for their patients. Additionally, we allow employers to see the benefits of lowering costs around both prescription- spending and overall healthcare while employing a healthier, more engaged staff. This comprehensive, personalized approach reduces interaction and efficacy risks while ensuring proper medications are being used for therapies. Precision Genetics combines genetic markers, molecular data, and clinical evidence into a comprehensive and actionable report, allowing busy physicians and providers to immediately develop individualized treatment and prevention plans for their patients. This comprehensive, personalized approach reduces interaction and efficacy risks while assuring proper therapy. Our interactive tools empower patients to utilize their molecular results to address their individual risks and treatment pathways based on their unique genetics, demographics, lifestyle, and medical conditions. Most importantly, a patient’s genetic risk analysis can be applied later in life as their risks increase; their health changes or new treatment pathways are identified.

Genetech Solutions is an IT staff augmentation and custom software development company helping startups and enterprises scale with dedicated engineering teams, AI-powered solutions, and cloud technologies. With over 17 years of experience, we enable businesses to augment their in-house teams with highly skilled software engineers, designers, QA specialists, and product managers without the overhead of traditional hiring. Our flexible engagement models allow companies to scale quickly, accelerate product development, and maintain full control of their roadmap. From traditional enterprise applications to intelligent AI-driven platforms, our team of 70+ technologists delivers secure, scalable, and future-ready solutions across diverse industries. We operate as long-term technology partners, not just vendors. With delivery capabilities across global markets and a strong presence in Pakistan’s growing tech ecosystem, we combine cost efficiency with technical excellence and strong communication standards. If you are looking for an agile, value-driven team to extend your engineering capacity or build mission-critical software, Genetech Solutions is ready to collaborate. We are active members of leading tech communities and proud recipients of the Pakistan Software House Association award for being the Most Gender Diverse Company in Pakistan. IT Staff Augmentation Dedicated Development Teams Offshore Engineering Teams Custom Software Design & Development Artificial Intelligence & Machine Learning Cloud Computing & Hosting Cybersecurity Backup & Disaster Recovery Mobile Application Development Brand Identity & Graphic Design